Global Conjunctivitis Drugs Market 2018-2024 – Increasing Clinical Trials & Rising Prevalence of Bacterial Conjunctivitis – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Conjunctivitis Drugs Market 2018-2024" report has been added to ResearchAndMarkets.com's offering. The Global Bacterial Conjunctivitis Drugs Market is estimated to witness a CAGR of 2.1% during the forecast period 2018-2024 Based on drug classes, the market is segmented into fluoroquinolones, aminoglycosides, macrolides, and others. Fluoroquinolones have a dominant market share for bacterial conjunctivitis. However, this drug class is likely to reduce its ma

Full Story →